![Roni Shouval: Treatment failure patterns in early vs late introduction of CAR T-cell therapy in large B-cell lymphoma](https://oncodaily.com/pub/uploads/2025/02/roni-e1738858486199.png)
Roni Shouval: Treatment failure patterns in early vs late introduction of CAR T-cell therapy in large B-cell lymphoma
Roni Shouval, Assistant Attending Adult BMT and Cellular Therapy Service at MSKCC, shared on X:
“New study out! Early (2nd-line) vs late (≥3rd-line) CAR-T in LBCL. While early CAR-T trended toward better OS (82% vs. 71%, p<.048), relapse remained high in both (37% vs. 43%, p=.2), challenging the idea that earlier use overcomes resistance. ”
Authors: Magdalena Corona, Andrew Ip, Samantha Brown, Alejandro Luna, Hazim Khatib, Jessica R. Flynn, Sean M. Devlin, Ivan Landego, Giulio Cassanello, Kai Rejeski, Tsila Zuckerman, Parastoo B. Dahi, Michael Scordo, Richard J. Lin, Maciej Kabat, Efrat Luttwak, Emma Pavkovic, M. Lia Palomba, Jae Park, Gilles Salles, Heiko Schoder, Doris Leithner, Lori A. Leslie, Miguel-Angel Perales, Ofrat Beyar-Katz, Gunjan L. Shah and Roni Shouval
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023